ACHP urges CMS to apply the 2026 hold harmless (“better-of”) methodology to the 2027 Medicare Advantage Star Ratings while the Clover Health litigation remains unresolved, preserving fairness, stability and predictability.
ACHP urges Congress to advance targeted health care transparency reforms that lower costs and protect consumers without adding duplicative reporting burdens.
ACHP letter to CMS Administrator Mehmet Oz calls for excluding preventive dental, routine vision and hearing exams from the Medicare Advantage Total Beneficiary Cost calculation to protect supplemental benefits and beneficiary choice.
ACHP issued a statement in response to the CY2027 Medicare Advantage and Part D Final Rule.
